A major discovery in cancer investigation is emerging with the use of nanobodies to re-engage dysfunctional p53. This essential malignant suppressor protein is frequently disabled in several kinds of malignancies, https://agendabookmarks.com/story21892315/vhh-fragments-reactivate-the-p53-protein-a-new-approach-for-tumor-management